Abbott Laboratories - 37 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of October 19, 2020 is 108.04.
  • The all-time high Abbott Laboratories stock closing price was 111.29 on August 27, 2020.
  • The Abbott Laboratories 52-week high stock price is 114.19, which is 5.7% above the current share price.
  • The Abbott Laboratories 52-week low stock price is 61.61, which is 43% below the current share price.
  • The average Abbott Laboratories stock price for the last 52 weeks is 91.32.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 92.8957 86.9500 111.2900 62.8200 108.0400 24.38%
2019 80.5399 69.5000 88.7400 66.2200 86.8600 20.09%
2018 64.2198 58.7900 74.2700 56.2700 72.3300 26.74%
2017 48.5437 39.0500 57.4700 39.0500 57.0700 48.58%
2016 40.4946 42.9300 45.2900 36.3400 38.4100 -14.47%
2015 46.3063 44.9000 51.2000 39.0600 44.9100 -0.24%
2014 40.9545 38.2300 46.3700 35.8500 45.0200 17.45%
2013 35.6540 32.0500 38.7100 32.0500 38.3300 -41.48%
2012 62.7592 56.7200 72.1300 54.1500 65.5000 16.49%
2011 51.0656 47.8200 56.3300 45.1600 56.2300 17.37%
2010 50.7320 54.4600 56.2400 45.8600 47.9100 -11.26%
2009 48.4288 53.5600 57.2500 41.5200 53.9900 1.16%
2008 55.1625 55.8100 60.5000 49.4500 53.3700 -4.95%
2007 54.4193 48.9700 59.4300 48.9700 56.1500 15.27%
2006 45.0284 39.5500 49.4800 39.5500 48.7100 23.54%
2005 45.3700 46.6700 49.9900 37.6300 39.4300 -15.48%
2004 42.3562 46.7500 46.9900 38.3600 46.6500 0.11%
2003 41.2709 40.0500 47.1500 34.3800 46.6000 16.50%
2002 45.8684 55.8400 57.7000 31.0000 40.0000 -28.25%
2001 50.0663 48.1300 56.7700 42.0600 55.7500 15.09%
2000 41.6982 35.0000 55.7500 29.6300 48.4400 33.41%
1999 43.6333 48.7500 52.9400 33.3100 36.3100 -25.90%
1998 40.9077 33.7200 49.7500 33.3450 49.0000 49.62%
1997 30.8148 25.1900 34.3150 25.1900 32.7500 29.06%
1996 22.6483 20.8750 28.3750 19.3750 25.3750 21.91%
1995 19.2416 16.3150 22.3150 15.6250 20.8150 27.58%
1994 14.8357 14.4400 16.8150 13.0650 16.3150 10.12%
1993 13.4211 15.1900 15.1900 11.5000 14.8150 -2.47%
1992 15.3475 16.8125 17.0300 13.5000 15.1900 -11.78%
1991 13.0176 10.8125 17.2175 9.9375 17.2175 53.04%
1990 9.5320 8.6563 11.3750 7.8750 11.2500 32.35%
1989 7.3855 5.9688 8.7663 5.8288 8.5000 41.28%
1988 5.8545 6.0788 6.5000 5.3750 6.0163 -0.25%
1987 7.1870 5.9375 8.3600 5.3750 6.0313 5.74%
1986 5.4847 4.2500 6.7963 3.9844 5.7038 33.48%
1985 3.4075 2.5394 4.3831 2.5000 4.2731 63.76%
1984 2.6840 2.8750 3.0000 2.3750 2.6094 -7.73%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $194.174B $31.904B
Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.038B 27.88
Stryker (SYK) United States $83.980B 32.56
Boston Scientific (BSX) United States $54.995B 31.77
Lonza Group Ag (LZAGY) Switzerland $48.550B 0.00
Baxter (BAX) United States $41.420B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.422B 25.25
EssilorLuxottica Societe Anonyme (ESLOY) France $29.732B 0.00
Terumo (TRUMY) Japan $29.086B 37.18
ResMed (RMD) United States $26.198B 37.98
Sunny Optical Technology (SNPTF) China $17.297B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.198B 0.00
Bio-Rad Laboratories (BIO) United States $16.518B 74.71
Insulet (PODD) United States $16.303B 689.81
DiaSorin S.p.A (DSRLF) Italy $12.169B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
Quidel (QDEL) United States $10.708B 56.72
GN STORE NORD (GNNDY) Denmark $9.996B 50.95
William Demant Holdings (WILYY) Denmark $7.850B 0.00
Canopy Growth (CGC) Canada $6.603B 0.00
Perrigo (PRGO) Ireland $6.466B 11.10
Hill-Rom Holdings (HRC) United States $5.963B 14.80
Haemonetics (HAE) United States $4.755B 31.68
Envista Holdings (NVST) United States $4.286B 29.23
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.232B 0.00
ICU Medical (ICUI) United States $4.170B 31.82
TG Therapeutics (TGTX) United States $3.824B 0.00
Neogen (NEOG) United States $3.788B 62.10
Abcam (ABCZY) $3.534B 0.00
National Vision Holdings (EYE) United States $3.282B 510.13
GW Pharmaceuticals (GWPH) United Kingdom $2.964B 0.00
NuVasive (NUVA) United States $2.742B 38.21
Agios Pharmaceuticals (AGIO) United States $2.479B 0.00
DFB Healthcare Acquisitions (AHCO) United States $2.373B 0.00
AtriCure (ATRC) United States $1.828B 0.00
Owens & Minor (OMI) United States $1.649B 36.94
Cardiovascular Systems (CSII) United States $1.548B 0.00
NanoString Technologies (NSTG) United States $1.527B 0.00
Aphria (APHA) Canada $1.343B 0.00
MacroGenics (MGNX) United States $1.321B 0.00
InMode (INMD) Israel $1.269B 32.02
Quanterix (QTRX) United States $1.204B 0.00
Cerus (CERS) United States $1.068B 0.00
OraSure Technologies (OSUR) United States $0.988B 0.00
PetIQ (PETQ) United States $0.932B 26.73
BioLife Solutions (BLFS) United States $0.901B 469.50
Lantheus Holdings (LNTH) United States $0.892B 12.36
Meridian Bioscience (VIVO) United States $0.775B 17.90
Vapotherm (VAPO) United States $0.759B 0.00
Phibro Animal Health (PAHC) United States $0.737B 16.87
LeMaitre Vascular (LMAT) United States $0.654B 39.89
Eagle Pharmaceuticals (EGRX) United States $0.632B 89.33
Omeros (OMER) United States $0.628B 0.00
Surmodics (SRDX) United States $0.567B 62.19
Varex Imaging (VREX) United States $0.533B 23.08
Zynex (ZYXI) United States $0.488B 42.61
Aurora Cannabis (ACB) Canada $0.464B 0.00
Surface Oncology (SURF) United States $0.376B 0.00
Cytosorbents (CTSO) United States $0.369B 0.00
HEXO (HEXO) $0.361B 0.00
Viemed Healthcare (VMD) United States $0.345B 12.32
Utah Medical Products (UTMD) United States $0.301B 25.82
InfuSystems Holdings (INFU) United States $0.264B 50.31
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.249B 0.00
Organigram Holdings (OGI) Canada $0.230B 0.00
Bovie Medical (APYX) United States $0.203B 0.00
Exagen (XGN) United States $0.201B 0.00
Wound Management Technologies (SMTI) United States $0.193B 0.00
Female Health (VERU) United States $0.179B 0.00
Chimerix (CMRX) United States $0.178B 0.00
Evolus (EOLS) United States $0.141B 0.00
Fonar (FONR) United States $0.137B 18.16
Liberty Health Sciences (LHSIF) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.098B 0.00
Capricor Therapeutics (CAPR) United States $0.094B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.081B 0.00
Rockwell Medical (RMTI) United States $0.077B 0.00
United-Guardian (UG) United States $0.069B 15.57
Trinity Biotech (TRIB) Ireland $0.066B 12.55
MTech Acquisition (KERN) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.063B 0.00
Nephros (NEPH) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.028B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.006B 0.00